Inovio Pharmaceuticals (INO) News Today $2.56 +0.17 (+7.11%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$2.56 0.00 (0.00%) As of 05:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Inovio Pharmaceuticals' (INO) Sell (E+) Rating Reaffirmed at Weiss Ratings2 hours ago | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?October 7 at 5:17 AM | marketbeat.comINOVIO Reports Inducement Grant Under Inducement PlanOctober 2, 2025 | prnewswire.comHPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsightSeptember 30, 2025 | finance.yahoo.comGoldman Sachs Group Inc. Cuts Position in Inovio Pharmaceuticals, Inc. $INOSeptember 29, 2025 | marketbeat.comINOVIO to Participate in Upcoming Scientific ConferencesSeptember 25, 2025 | prnewswire.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 22, 2025 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Stock Passes Above 200 Day Moving Average - Should You Sell?September 17, 2025 | marketbeat.comNuveen LLC Invests $168,000 in Inovio Pharmaceuticals, Inc. $INOSeptember 8, 2025 | marketbeat.comZacks Research Downgrades Inovio Pharmaceuticals (NASDAQ:INO) to HoldSeptember 7, 2025 | marketbeat.comInovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)September 5, 2025 | seekingalpha.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Average Recommendation of "Moderate Buy" from BrokeragesAugust 30, 2025 | marketbeat.comInovio: Back On Track With INO-3107 BLA For RRP Before End Of 2025August 28, 2025 | seekingalpha.comINOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in AdultsAugust 26, 2025 | prnewswire.comStonepine Capital Management LLC Sells 531,669 Shares of Inovio Pharmaceuticals, Inc. $INOAugust 26, 2025 | marketbeat.comINOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 25, 2025 | prnewswire.comHC Wainwright Has Optimistic Outlook of INO Q3 EarningsAugust 19, 2025 | marketbeat.comWall Street Zen Downgrades Inovio Pharmaceuticals (NASDAQ:INO) to SellAugust 17, 2025 | marketbeat.comInovio Pharmaceuticals' (INO) "Neutral" Rating Reiterated at HC WainwrightAugust 16, 2025 | marketbeat.comCitizens JMP Sticks to Its Buy Rating for Inovio Pharmaceuticals (INO)August 15, 2025 | theglobeandmail.comInovio Pharmaceuticals (INO) Receives a Buy from Piper SandlerAugust 15, 2025 | theglobeandmail.comInovio Pharmaceuticals Second Quarter 2025 Earnings: US$0.61 loss per share (vs US$1.19 loss in 2Q 2024)August 15, 2025 | finance.yahoo.comInovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings ResultsAugust 14, 2025 | marketbeat.comInovio Pharmaceuticals Inc. Research & Ratings | INO | Barron'sAugust 14, 2025 | barrons.comInovio rises after promising Q2 resultsAugust 13, 2025 | msn.comInovio Pharmaceuticals Reports Q2 2025 Financial ProgressAugust 13, 2025 | msn.comINOVIO Pharmaceuticals, Inc.: INOVIO Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 13, 2025 | finanznachrichten.deInovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comINOVIO Reports Second Quarter 2025 Financial Results and Recent Business HighlightsAugust 12, 2025 | prnewswire.comEarnings Outlook For Inovio PharmaceuticalsAugust 11, 2025 | benzinga.comData Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)August 11, 2025 | prnewswire.comInovio Pharmaceuticals (INO) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comINOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025August 4, 2025 | prnewswire.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesAugust 4, 2025 | marketbeat.comInovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gainsJuly 22, 2025 | marketwatch.comInovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gainsJuly 18, 2025 | marketwatch.comInovio Pharmaceuticals, Inc. (INO) Latest Stock News & Headlines ...July 13, 2025 | finance.yahoo.comPiper Sandler Initiates Coverage of Inovio Pharmaceuticals (INO) with Overweight RecommendationJuly 10, 2025 | msn.comInovio wins new Overweight at Piper Sandler on potential FDA nod for lead drugJuly 9, 2025 | msn.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of "Moderate Buy" by AnalystsJuly 9, 2025 | marketbeat.comINOVIO Announces Public Offering of Common Stock and WarrantsJuly 7, 2025 | msn.comINOVIO to Present at Upcoming Scientific ConferenceJuly 7, 2025 | prnewswire.comInovio Pharmaceuticals Inc. (INO) Stock Price Today - WSJJuly 3, 2025 | wsj.comInovio Pharmaceuticals Stock Falls After Pricing OfferingJuly 3, 2025 | marketwatch.comINOVIO Announces Pricing of $25 Million Public OfferingJuly 3, 2025 | prnewswire.comInovio Pharmaceuticals (NASDAQ:INO) Stock Price Passes Above 200-Day Moving Average - Should You Sell?July 3, 2025 | marketbeat.comInovio Pharmaceuticals stock plunges after announcing public offeringJuly 2, 2025 | uk.investing.comInovio Pharma Shares Slide on Plans for Public OfferingJuly 2, 2025 | marketwatch.comINOVIO Announces Proposed Public OfferingJuly 2, 2025 | prnewswire.comAvacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business DevelopmentJuly 1, 2025 | globenewswire.com Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INO Media Mentions By Week INO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INO News Sentiment▼0.580.63▲Average Medical News Sentiment INO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INO Articles This Week▼23▲INO Articles Average Week Get the Latest News and Ratings for INO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Inovio Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Moderna News OrthoPediatrics News CeriBell News Semler Scientific News Treace Medical Concepts News Delcath Systems News Alpha Tau Medical News NeuroPace News RxSight News Tactile Systems Technology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
